ZARCONE DONNA F 4

What Happened

• Donna F. Zarcone, a director of The Cigna Group (CI), was granted 782 shares reported as an award/acquisition (code A) on April 22, 2026. The transaction is reported at an acquisition price of $0.00 in the Form 4 (i.e., awarded shares rather than an open-market purchase).

Key Details

• Transaction date: 2026-04-22; Report filed: 2026-04-24.
• Transaction type/code: Award/Grant (A); reported acquisition price $0.00 for 782 shares.
• Shares owned after transaction: Not specified in the Table I reporting (the filing does not list a post-transaction beneficial ownership total).
• Footnote F1: The reporting person also has hypothetical common-stock–linked units that are settled in cash upon separation; those cash-settled units are excluded from Table I. The footnote directs readers to the insider’s Section 16 filings and The Cigna Group proxy (pages 51–52 and 118) for more detail.
• Remarks: Exhibit 24 (Power of Attorney) is attached to the filing.
• Timeliness: Report filed two days after the transaction date (Apr 22 → Apr 24).

Context

• This was a compensation award, not an open-market purchase. Awards like this are typically part of director pay programs and don’t necessarily indicate the insider’s near-term trading intent or market view.
• For retail investors tracking insider activity, purchases (cash buys) can be more informative about sentiment; grants/awards primarily reflect compensation.